Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01186341 · ClinicalTrials.gov registry record
BraveNet Multi-Center Study on Integrative Medicine Treatment Approaches for Pain
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 418
- Enrollment target
NCT01186341: Completed study, sponsored by Duke University.
NCT01186341 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 418 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01186341 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 418 participants
- Enrollment target
Study Summary
Preliminary results from an ongoing cross-sectional survey of nine of the BraveNet Outpatient Clinics indicate that pain was the leading reason for patient visits. As a precursor to a large multi-site clinical trial, this study aims to determine the feasibility of collecting outcomes data on integrative treatment for pain. These preliminary data will also provide an estimation of effect size for powering the multi-site clinical trial.
Primary Outcome
As measured by the number of patients approached to participate, number who refuse to participate, reasons for refusal, and the number of people who provide consent.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 418 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-06 |
What the finished NCT01186341 record still lists
NCT01186341 is an observational study that tracks outcomes without assigning an intervention. The registered 418 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01186341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01186341 about?
NCT01186341 is a clinical study titled "BraveNet Multi-Center Study on Integrative Medicine Treatment Approaches for Pain". Preliminary results from an ongoing cross-sectional survey of nine of the BraveNet Outpatient Clinics indicate that pain was the leading reason for patient visits. As a precursor to a large multi-site clinical trial, this study aims to determine the feasibility of collecting outcomes data on integra...
What is the current status of trial NCT01186341?
This trial is currently completed. The enrollment target is 418 participants. The study started on 2009-06. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT01186341?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03135886 · 418 participants · NA
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
- NCT05579639 · 419 participants · Phase 2
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
- NCT06169735 · 417 participants · Phase 4
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
- NCT06699901 · 417 participants
Antibiotic Concentrations After MassivE Transfusion Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia